IME West | February 7-9, 2023 | Anaheim Convention Center, Anaheim, CA

Biocompatibility Explained – A Primer and Refresher; an Educational Coffee Talk Session Hosted by Labcorp

Wednesday, February 8th from 9:45 – 10:30 a.m. PST
Location: Room 211AB

Biocompatibility is a complex and ever-changing topic and this talk will review:

  • What is biocompatibility?
  • How to classify a device and select endpoints for analysis
  • Difference between horizontal and vertical standards and FDA guidance documents
  • Common differences between ISO 10993-1 and FDA expectations
  • Sample preparation for testing
  • What standards are most commonly used for the evaluation of each endpoint
  • Introduction to common biocompatibility methods


Chris Parker, Ph.D.

Chris Parker, Ph.D.
Associate Department Head, In Vivo Biocompatibility, Labcorp

Chris Parker is the Associate Department Head of In-Vivo Biocompatibility at Labcorp Bedford. Since joining Labcorp in 2007, Mr. Parker has worked closely with medical device manufacturers to develop their testing programs and support their regulatory product submissions. His areas of expertise include medical device biocompatibility and efficacy modeling. Mr. Parker has authored numerous journal publications and white papers, and is a member of many AAMI BE and ISO TC/194 working groups for ISO 10993. Mr. Parker received his B.S. and M.S. in biology/biotechnology from Worcester Polytechnic Institute and his M.B.A. from Bentley University with a focus on scientific operations and marketing.



Informa values your privacy. To fully understand how we use your data, please see our Privacy Policy.

(60 characters max)
(40 characters max)